The effect of conjugated linoleic acid supplementation in improving of children pulmonary infection

The effect of conjugated linoleic acid supplementation in improving of children pulmonary infection at 1-5 years old in Boali Hospital, Ardabil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201402235144N6

Enrollment

Registered

2014-07-20

Start date

2014-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children with lower respiratory tract infection.. Other acute lower respiratory infections

Interventions

Intervention 1: Intervention group: Two grams of conjugated linoleic acid for 2 weeks. Intervention 2: Control group: Was not given anything.

Treatment - Drugs

Intervention group: Two grams of conjugated linoleic acid for 2 weeks.

Control group: Was not given anything

Eligibility

Sex/Gender

All

Age

93 Years to 93 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Children with pulmonary infection in 1-5 years old; in Buali Hospital; Ardabil Exclusion criteria: Children with malnutrition and chronic disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Respiratory infection. Timepoint: At the end of treatment. Method of measurement: Signs and symptoms related to diease.	—

Secondary

Measure	Time frame
Weight. Timepoint: At the beginning and after two weeks intervention. Method of measurement: Digital scales.;Body Mass Index. Timepoint: At the beginning and after two weeks intervention. Method of measurement: Stadiometers.;Appetite. Timepoint: At the beginning and two weeks after the intervention. Method of measurement: Questionnaire.;Cough. Timepoint: At the beginning and after two weeks intervention. Method of measurement: Questionnaire.;Fever. Timepoint: At the beginning and after two weeks intervention. Method of measurement: Questionnaire.;Sore throat. Timepoint: At the beginning and after two weeks intervention. Method of measurement: Questionnaire.;Respiratory distress. Timepoint: At the beginning and after two weeks intervention. Method of measurement: Questionnaire.	—

Measure

Time frame

Weight. Timepoint: At the beginning and after two weeks intervention. Method of measurement: Digital scales.;Body Mass Index. Timepoint: At the beginning and after two weeks intervention. Method of measurement: Stadiometers.;Appetite. Timepoint: At the beginning and two weeks after the intervention. Method of measurement: Questionnaire.;Cough. Timepoint: At the beginning and after two weeks intervention. Method of measurement: Questionnaire.;Fever. Timepoint: At the beginning and after two weeks intervention. Method of measurement: Questionnaire.;Sore throat. Timepoint: At the beginning and after two weeks intervention. Method of measurement: Questionnaire.;Respiratory distress. Timepoint: At the beginning and after two weeks intervention. Method of measurement: Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParisa Ahadi Kalkhoran

Ardabil University Of Medical Science

ali.nemati@arums.ac.ir+98 45 1771 3310

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026